Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
When testicular cancer is diagnosed, tests will be performed to determine how much cancer is present, and if the cancer has spread from the testis to other parts of the body. This is called staging, and is an important step toward planning a treatment program.
As defined by the National Cancer Institute (NCI), the stages of testicular cancer include the following:
Stage I the cancer is limited to the testis
Stage II the cancer involves the testis and has spread to lymph nodes in the lower abdomen
Stage III the cancer has spread to lymph nodes outside of the lower abdomen, to the lungs, or to another organ
Procedures for determining stage include the following:
Computed tomography scan (CT or CAT scan)
Lymphangiography: Images of the lymph system in which dye is injected into a lymph vessel to improve images.
Magnetic resonance imaging (MRI)
In addition to these imaging procedures, chest X-rays, positron emission tomography (PET) scans, or other scans may be requested.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.